Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder.
作者信息
Springer Sandra A
机构信息
Yale University AIDS Program, New Haven, Connecticut.
出版信息
Clin Infect Dis. 2020 Jun 10;70(12):2703-2705. doi: 10.1093/cid/ciz695.
Abstract
摘要
相似文献
1
Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder.使用药物并接受阿片类物质使用障碍药物治疗的人群中丙型肝炎病毒再感染率
Clin Infect Dis. 2020 Jun 10;70(12):2703-2705. doi: 10.1093/cid/ciz695.
2
It's Not Them, It's Us: Hepatitis C Reinfection Following Successful Treatment Among People Who Inject Drugs.不是他们的问题，而是我们的问题：注射吸毒者成功治疗后丙型肝炎再感染情况
Clin Infect Dis. 2021 Apr 26;72(8):1401-1403. doi: 10.1093/cid/ciaa258.
3
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.注射吸毒者抗病毒治疗成功后的丙型肝炎再感染：一项荟萃分析。
J Hepatol. 2020 Apr;72(4):643-657. doi: 10.1016/j.jhep.2019.11.012. Epub 2019 Nov 27.
4
A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.慢性丙型肝炎病毒感染者接受阿片类激动剂治疗后的病毒传播、复发和再感染的系统进化分析。
J Infect Dis. 2020 Jul 6;222(3):488-498. doi: 10.1093/infdis/jiaa100.
5
Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland.在瑞士苏黎世的一个多学科治疗中心，接受直接作用抗病毒治疗的患者中，丙型肝炎的再感染。
Int J Drug Policy. 2021 Oct;96:103434. doi: 10.1016/j.drugpo.2021.103434. Epub 2021 Sep 9.
6
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.在接受直接作用抗病毒治疗成功清除丙型肝炎病毒感染的吸毒者中再次感染。
Clin Infect Dis. 2021 Apr 26;72(8):1392-1400. doi: 10.1093/cid/ciaa253.
7
Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era.德国经直接作用抗病毒药物治疗后成功的男男性行为者中丙型肝炎病毒再感染：当前的发病率与干扰素时代的发病率比较。
Clin Infect Dis. 2020 Aug 22;71(5):1248-1254. doi: 10.1093/cid/ciz949.
8
Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.慢性丙型肝炎患者接受阿片类激动剂治疗的治疗：最佳实践综述。
Infect Dis Clin North Am. 2018 Jun;32(2):347-370. doi: 10.1016/j.idc.2018.02.001.
9
Challenges in hepatitis C elimination despite highly effective antiviral agents in patients with and without intravenous drug use.尽管有高效的抗病毒药物，但在有和没有静脉吸毒的丙型肝炎患者中消除丙型肝炎仍面临挑战。
Wien Klin Wochenschr. 2021 Jul;133(13-14):641-646. doi: 10.1007/s00508-021-01868-1. Epub 2021 May 25.
10
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.同时启动丙型肝炎和阿片类药物使用障碍治疗在注射吸毒者中。
Clin Infect Dis. 2020 Oct 23;71(7):1715-1722. doi: 10.1093/cid/ciaa105.
引用本文的文献
1
Women and Treatment for Opioid Use Disorder: Contributors to Treatment Success From the Perspectives of Women in Recovery, Women With Past Attempts in Drug Treatment, and Health and Criminal Justice Professionals.女性与阿片类物质使用障碍治疗：从康复女性、曾尝试药物治疗的女性以及健康和刑事司法专业人员的视角看治疗成功的因素
Subst Use. 2024 Jan 10;18:11782218231222339. doi: 10.1177/11782218231222339. eCollection 2024 Jan-Dec.
2
Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection.针对丙型肝炎感染患者的丙型肝炎再感染预防干预措施的开发与预试验。
Drug Alcohol Depend Rep. 2022 Mar 11;3:100038. doi: 10.1016/j.dadr.2022.100038. eCollection 2022 Jun.
3
A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes.一项评估阿片类物质使用障碍药物治疗对传染病结局影响的研究的系统评价和荟萃分析。
Open Forum Infect Dis. 2021 Jun 2;8(8):ofab289. doi: 10.1093/ofid/ofab289. eCollection 2021 Aug.
4
Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018.医疗保健获取和利用在医疗补助扩张和非扩张州的注射毒品者中：22 个美国城市，2018 年。
J Infect Dis. 2020 Sep 2;222(Suppl 5):S420-S428. doi: 10.1093/infdis/jiaa337.
5
Co-located Opioid Use Disorder and Hepatitis C Virus Treatment Is Not Only Right, But It Is Also the Smart Thing To Do as It Improves Outcomes!同时开展阿片类物质使用障碍和丙型肝炎病毒治疗不仅正确，而且是明智之举，因为这样能改善治疗效果！
Clin Infect Dis. 2020 Oct 23;71(7):1723-1725. doi: 10.1093/cid/ciaa111.
本文引用的文献
1
Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.在接受阿片类激动剂治疗的药物注射者中，直接作用抗病毒治疗后丙型肝炎再感染率较低。
Clin Infect Dis. 2020 Jun 10;70(12):2695-2702. doi: 10.1093/cid/ciz693.
2
Nonopioid Overdose Death Rates Rose Almost As Fast As Those Involving Opioids, 1999-2016.1999-2016 年，非阿片类药物过量死亡率的上升速度几乎与阿片类药物相同。
Health Aff (Millwood). 2019 Jul;38(7):1216-1224. doi: 10.1377/hlthaff.2018.05522.
3
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison.在美国扩大丙型肝炎预防和治疗干预措施以实现消除目标：农村与城市比较。
Am J Epidemiol. 2019 Aug 1;188(8):1539-1551. doi: 10.1093/aje/kwz097.
4
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.阿片类激动剂治疗剂量、患者感知的剂量充足性以及注射吸毒者丙型肝炎感染风险。
CMAJ. 2019 Apr 29;191(17):E462-E468. doi: 10.1503/cmaj.181506.
5
Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs - Seattle, Washington, 2018.2018 年，华盛顿州西雅图市无家可归且注射吸毒的异性恋者中发生人类免疫缺陷病毒感染疫情。
MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):344-349. doi: 10.15585/mmwr.mm6815a2.
6
Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.接受阿片类激动剂治疗的注射吸毒者的丙型肝炎强化护理模式：一项随机对照试验。
Ann Intern Med. 2019 May 7;170(9):594-603. doi: 10.7326/M18-1715. Epub 2019 Apr 9.
7
Notes from the Field: HIV Diagnoses Among Persons Who Inject Drugs - Northeastern Massachusetts, 2015-2018.实地记录：马萨诸塞州东北部注射吸毒者中的艾滋病毒诊断情况，2015 - 2018年
MMWR Morb Mortal Wkly Rep. 2019 Mar 15;68(10):253-254. doi: 10.15585/mmwr.mm6810a6.
8
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.在大型基于人群的队列中，使用直接作用抗病毒治疗成功治疗后丙型肝炎病毒再感染。
J Hepatol. 2018 Nov;69(5):1007-1014. doi: 10.1016/j.jhep.2018.07.025. Epub 2018 Aug 22.
9
Integrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop.将阿片类药物使用障碍和传染病流行的治疗融入医疗环境：国家科学院、工程院和医学研究所研讨会之后的行动呼吁。
Ann Intern Med. 2018 Sep 4;169(5):335-336. doi: 10.7326/M18-1203. Epub 2018 Jul 13.
10
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.一项评估阿片类激动剂治疗的注射吸毒者中丙型肝炎病毒治疗三种护理模式的试验的原理、设计和方法
BMC Infect Dis. 2018 Feb 9;18(1):74. doi: 10.1186/s12879-018-2964-5.
Zotero 插件